Oxotremorine

Oxotremorine is a drug that acts as a selective muscarinic acetylcholine receptor agonist.[1]

Oxotremorine

Clinical data
Pregnancy category	C
Routes of administration	Oral, intravenous
ATC code	none
Legal status
Legal status	US: Experimental/not yet approved
Identifiers
IUPAC name 1-(4-Pyrrolidin-1-ylbut-2-yn-1-yl)pyrrolidin-2-one
CAS Number	70-22-4 Y
IUPHAR/BPS	302
ChemSpider	4469 N
ChEMBL	ChEMBL7634 N
CompTox Dashboard (EPA)	DTXSID10220252
ECHA InfoCard	100.000.662
Chemical and physical data
Formula	C12H18N2O
Molar mass	206.28 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CCN(C1)CC#CCN2CCCC2=O
InChI InChI=InChI=1S/C12H18N2O/c15-12-6-5-11-14(12)10-4-3-9-13-7-1-2-8-13/h1-2,5-11H2 N Key:RSDOPYMFZBJHRL-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Oxotremorine produces ataxia, tremor and spasticity, similar to those symptoms seen in Parkinsonism, and has thus become a research tool in experimental studies aimed at determining more effective anti-Parkinsonian drugs.[2]

Oxotremorine also produces antipsychotic effects.[3]